1. Home
  2. GE vs NVS Comparison

GE vs NVS Comparison

Compare GE & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Electric Company

GE

General Electric Company

HOLD

Current Price

$283.38

Market Cap

318.8B

Sector

Technology

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$144.70

Market Cap

286.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GE
NVS
Founded
1892
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
318.8B
286.9B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
GE
NVS
Price
$283.38
$144.70
Analyst Decision
Strong Buy
Hold
Analyst Count
12
5
Target Price
$345.25
$144.00
AVG Volume (30 Days)
5.9M
1.3M
Earning Date
04-21-2026
04-28-2026
Dividend Yield
0.66%
2.12%
EPS Growth
35.89
N/A
EPS
1.81
N/A
Revenue
$45,855,000,000.00
N/A
Revenue This Year
$8.37
$2.30
Revenue Next Year
$10.25
$5.27
P/E Ratio
$157.18
$23.13
Revenue Growth
18.48
N/A
52 Week Low
$196.86
$108.53
52 Week High
$348.48
$170.46

Technical Indicators

Market Signals
Indicator
GE
NVS
Relative Strength Index (RSI) 42.54 33.94
Support Level $262.74 $122.16
Resistance Level $314.16 $146.35
Average True Range (ATR) 10.11 1.97
MACD -1.82 -0.69
Stochastic Oscillator 28.88 4.23

Price Performance

Historical Comparison
GE
NVS

About GE General Electric Company

GE Aerospace is the global leader in designing, manufacturing, and servicing commercial aircraft turbine engines, along with partner Safran in their CFM joint venture. With its massive global installed base of nearly 80,000 commercial and military engines, GE Aerospace earns most of its profits on recurring service revenue of that equipment, which operates for decades. GE Aerospace is the remaining core business of the company formed in 1892 with historical ties to American inventor Thomas Edison; that company became a storied conglomerate with peak revenue of $130 billion in 2000 until GE spun off its appliance, finance, healthcare, and wind and power businesses between 2016 and 2024.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: